Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Oct. 10, 2024 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises ADMA Biologics, Inc. (“ADMA Biologics” or “the Company”) (NASDAQ: ADMA) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. ADMA Biologics investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
“Shares fell over 18% on Thursday, following the announcement that CohnReznick is no longer the independent registered public accounting firm, as indicated in the Form 10-Q filing for the quarter ending September 30.”
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bars
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow